Treasurer Of The State Of North Carolina Biogen Inc. Transaction History

Treasurer Of The State Of North Carolina

$25 Billion
Q3 2024

A detailed history of Treasurer Of The State Of North Carolina transactions in Biogen Inc. stock. As of the latest transaction made, Treasurer Of The State Of North Carolina holds 91,367 shares of BIIB stock, worth $13.4 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

91,367

Previous 97,355 6.15%

Holding current value

$13.4 Million

Previous $22.6 Million 21.53%

% of portfolio

0.07%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $1.13 Million - $1.42 Million	-5,988 Reduced 6.15%	91,367 $17.7 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $739,598 - $918,947	3,882 Added 4.15%	97,355 $22.6 Million
Q1 2024 May 09, 2024	SELL	$212.02 - $267.71 $504,395 - $636,882	-2,379 Reduced 2.48%	93,473 $20.2 Million
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $803,327 - $966,995	3,609 Added 3.91%	95,852 $24.8 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $260,899 - $294,466	1,030 Added 1.13%	92,243 $23.7 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $783,912 - $905,834	-2,848 Reduced 3.03%	91,213 $26 Million
Q1 2023 May 04, 2023	BUY	$256.56 - $292.34 $616,513 - $702,493	2,403 Added 2.62%	94,061 $26.2 Million
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $2.14 Million - $2.6 Million	-8,472 Reduced 8.46%	91,658 $25.4 Million
Q3 2022 Nov 08, 2022	SELL	$194.69 - $268.46 $3,699 - $5,100	-19 Reduced 0.02%	100,130 $26.7 Million
Q2 2022 Aug 02, 2022	SELL	$187.54 - $223.02 $72,390 - $86,085	-386 Reduced 0.38%	100,149 $20.4 Million
Q1 2022 May 10, 2022	BUY	$193.77 - $244.14 $480,162 - $604,978	2,478 Added 2.53%	100,535 $21.2 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $1.8 Million - $2.31 Million	8,042 Added 8.93%	98,057 $23.5 Million
Q3 2021 Nov 03, 2021	SELL	$282.99 - $369.05 $827,745 - $1.08 Million	-2,925 Reduced 3.15%	90,015 $25.5 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $202,020 - $323,473	-780 Reduced 0.83%	92,940 $32.2 Million
Q1 2021 May 03, 2021	SELL	$242.95 - $284.63 $347,904 - $407,590	-1,432 Reduced 1.5%	93,720 $26.2 Million
Q4 2020 Feb 02, 2021	BUY	$236.26 - $355.63 $1.9 Million - $2.87 Million	8,060 Added 9.25%	95,152 $23.3 Million
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $20,387 - $23,539	-77 Reduced 0.09%	87,092 $24.7 Million
Q2 2020 Aug 07, 2020	SELL	$258.66 - $342.55 $4.35 Million - $5.77 Million	-16,830 Reduced 16.18%	87,169 $23.3 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $910,057 - $1.15 Million	3,385 Added 3.36%	103,999 $32.9 Million
Q4 2019 Feb 12, 2020	BUY	$220.06 - $304.07 $964,302 - $1.33 Million	4,382 Added 4.55%	100,614 $29.9 Million
Q3 2019 Nov 07, 2019	SELL	$217.44 - $243.88 $7.45 Million - $8.35 Million	-34,250 Reduced 26.25%	96,232 $22.4 Million
Q2 2019 Aug 23, 2019	BUY	$219.29 - $241.72 $1.02 Million - $1.13 Million	4,674 Added 3.72%	130,482 $30.5 Million
Q1 2019 Aug 07, 2019	SELL	$216.71 - $338.96 $294,075 - $459,968	-1,357 Reduced 1.07%	125,808 $29.7 Million
Q4 2018 Aug 07, 2019	BUY	$278.5 - $352.75 $384,051 - $486,442	1,379 Added 1.1%	127,165 $38.3 Million
Q3 2018 Aug 07, 2019	BUY	$293.51 - $383.83 $11.4 Million - $15 Million	38,994 Added 44.93%	125,786 $44.4 Million
Q2 2018 Aug 07, 2019	BUY	$257.52 - $306.91 $13.9 Million - $16.5 Million	53,920 Added 164.03%	86,792 $25.2 Million
Q1 2018 Jul 24, 2019	BUY	$260.13 - $367.91 $8.55 Million - $12.1 Million	32,872 New	32,872 $9 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Treasurer Of The State Of North Carolina, based on Form 13F filings with the SEC.

News

Stay updated on Treasurer Of The State Of North Carolina with notifications on news.

Account

Treasurer Of The State Of North Carolina Biogen Inc. Transaction History